The study of Mahboobifard et al., in which the results showed higher serum prolactin levels in women with PCOS (aged ≤35 years) compared to health controls, substantiate the underlying pathway of a lower dopaminergic control. This evidence concerns the gene PRL and polycystic ovary syndrome.